OMEGA-3 DHA THERAPY™

Deluxe Therapy For Preventive Care*


"We concientiously produced a more powerful product optimized for scientifically proven results, guaranteed."
OMEGA-3 DHA THERAPY™
Clinically Optimized Formula
4 Capsules Have
> 2400 mg Omega3 DHA
[DHA, the only omega-3 proven to stay cognitive decline]
> 80 mg EPA
[EPA, a powerful anti-inflammatory for vascular health]
"The whole experience was thoughtful and easy to follow. I'm so glad I found your site. I'm planning on telling my friends and family about your company and product."
PURE ONE™ Satisfied Customer

omega-3 DHA
BUY 10 to get 2 FREE
(3 to 6 month supply)
> FREE CONSULTATION
Omega Deluxe Package Deal:
> Premium customer support with
customized support information.
> One free consultation (email, phone or meeting)
with Dr. Doughman to help you decide on your omega-3
doses, uses, and choices.
> PURE ONE™ Deluxe Therapy includes PURE ONE™ at 2 to 4
bottles/month for 3 months.
> You also get a FREE 3 month follow-up supporting the
guaranteed satisfaction we promise.
Why is brain DHA reduced in people with Alzheimer's Disease?
Profound DHA Deficiency!
Alzheimer's Disease is NOT Genetic
Only about 10% of Alzheimer's cases are ever genetic. Just by including higher DHA levels in the diet with supplements, you may have struck upon the answer to the number one all-dementia preventative that could benefit up to 70% of adults by preventing Alzheimer's onset triggers in the first place.
Here is the report: John Hopkins Health Alert
Even those who have been diagnosed with Alzheimer's Disease could be helped by slowing the rate of decline due to the progression of the disease.
"Because with Omega-3s people
do need the clinical benefits that PURE ONE™
DHA now makes available to everyone."
- Dr. Doughman
Dr. Doughman speaks your language.
He's passionate about helping you achieve one specific goal.
Dr. Doughman is an educator and consultant on Omega-3 DHA Therapy™.
This therapy aims to double circulating omega-3 levels in only 3 months.
He consults with you directly, ABSOLUTELY FREE, call him today.
1-919-360-5275
Customer Care:
Dr. Doughman is available to answer any pressing question, generally within 24 hours.
Ask for Dr. Doughman anytime during regular business hours [left].
PURE ONE™ is available exclusively HERE from Source-Omega, LLC. The
Manufacturer and Distributor of PURE ONE™ Optimized Omega3™
ALL RIGHTS RESERVED
PHASE III Clinical Trial with Microalgae Oil DHA Drug may soon Address the Cause and the Cure of Most Dementia.

|
Official Title: PHASE III |
A Randomized Double-Blind Placebo-Controlled Trial Of The Effects Of Docosahexaenoic Acid (DHA) In Slowing The Progression Of Alzheimer's Disease |
Study Dose: 2000 mg DHA daily of Microalgae Oil DHA
Further study details as provided by National Institute on Aging (NIA):
http://clinicaltrials.gov/ct/show/NCT00440050
Dr Doughman's Conclusions:
"The official guidance is that clinical DHA levels are being tested in Alzheimer’s studies using the omega-3 DHA natural products made by select microalgae to obtain super-concentrated DHA capsules.
The dose being tested by the NIH funded Phase III Human Study is 2 grams of DHA per day to quantify the significant gains again in a larger population for the treatment and prevention of dementia with just the drug DHA.
"My opinion is the DHA drug will be available after another 2 to 3 years. Pharmaceutical DHA capsules are in trials and not yet available, but our highly trusted Clinical Grade oil is taken as the preferred choice of clinicians for their own families.
"Only Pure One™ by Source-Omega™ makes a microalgae oil product optimized to deliver 2.4 grams of DHA per day in only 8 capsules. You would need 20 capsules of fish oil per day to get the same or higher amount of vital DHA used in the clinical trial.
"Now the most convenient way to complete any Omega-3 therapy is with Pure One™.
"Because your Omega-3s should be Golden."
Special Notes:
The entire Source-Omega team takes Omega-3 DHA at recommended levels.
Only 12 weeks for clinically proven benefits from DHA by doubling your omega-3 status.
DELUXE THERAPY
Buy 5 PURE ONE™ get 1 FREE
Is it slowing recall, not slipping?
Most of us would be happy just to keep our mental recall from waning with age – a process that seems to start disturbingly early. If you are over 30, experts say you are on your way and that your memory could be slipping. Scientists now know that much of the decline in recall of most individuals represents slowing recall, not slipping or memory loss.
Alzheimer's is considered a preventable disease in many cases. Though its exact causes are still being discovered, scientists have discovered that Omega-3s, especially DHA are essential for neurocognitive development and normal brain functioning. The latest studies have indicated that adequate consumption of Omega-3s (especially DHA) is helping reduce the incidence of Alzheimer's Disease, general cognitive decline and stroke. Just eliminating DHA deficiency in the brain may reduce up to 70% of Alzheimer's cases.
What You Can Do?
As we age, our neurons can shorten and lose contacts. We need to nurture our brain health like our heart health. The latest study had its test subjects consuming fish oil 3x a day. Few of us can do that. Also, the farm-raised fish available to most of us is much lower in DHA concentrations than wild fish. Increasing consumption of wild fish only puts more pressure on the Earth's declining fish stocks and increases our exposure to mercury and other fish contaminants.
The best thing you can do is to add Omega-3 supplements to your diet. Remember: while there are prescription drugs to lower cholesterol and treat other heart conditions, no medications are currently available to help prevent Alzheimer's and other brain diseases. Don't stop with taking supplements. Your lifestyle is also extremely important.
- Stay Active. Exercise both your body and your brain. Ironically, studies have found that people who regularly work crossword puzzles and brain teasers like Sudoku, significantly extend the time their brains stay sharp and improve their memory.
- Be Social. Staying involved in your community, helping others, and generally staying involved in the world around you is shown to be another key way to keep your brain sharp and alert.
- Strive to Learn. We should never stop trying to learn. Every class we take, no matter how old we are, and every new activity or idea we undertake, exercises your brain and increases the chance it will keep working well for many years to come.
“DHA is reduced in the brain of people with Alzheimer’s Disease”
National Institute on Aging (NIH: http://www.nia.nih.gov/ )
http://www.webmd.com/alzheimers/news/20070418/omeg-3-fatty-acid-slows-alzheimers
http://www.medicalnewstoday.com/articles/54404.php
http://www.worldhealth.net/news/how_dha_fights_alzheimer_s
http://clinicaltrials.gov/ct/show/NCT00440050
Statement below is from the paragraph found at the link here:
http://www.nia.nih.gov/Alzheimers/Publications/ADProgress2005_2006/Part2/healthydiet.htm.htm
This research team also examined the effects of another dietary component—the omega-3 fatty acid called docosahexaenoic acid (DHA), which is found in abundance in some kinds of fish. DHA is a primary component of the membranes of nerve cells in the brain and is involved in multiple brain functions, including nerve cell communication. DHA is reduced in the brains of people with AD, and some evidence suggests that higher levels of DHA in the blood may be protective for dementia and AD (Schaefer et al., 2006). In studies with transgenic mice, the researchers found that deficits in DHA can damage brain biochemistry, structure, and cognitive abilities (Calon et al., 2004). In contrast, a diet high in DHA reduced beta-amyloid and reduced the overall amount of plaque in the brain, especially in the hippocampus and parietal cortex, and reduced the amount of APP, the beta-amyloid precursor protein (Lim et al., 2005; Cole et al., 2005).
Arch Neurol. 2006 Nov;63(11):1527-8.
Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: the Framingham Heart Study.
Schaefer EJ, Bongard V, Beiser AS, Lamon-Fava S, Robins SJ, Au R, Tucker KL, Kyle DJ, Wilson PW, Wolf PA.
Lipid Metabolism Laboratory, Jean Mayer US Department of Agriculture Human Nutrition REsearch Center on Aging, Tuffs University, Boston, MA 02111, USA. ernst.schaefer@tufts.edu
CONCLUSION: The top quartile of plasma PC DHA level was associated with a significant 47% reduction in the risk of developing all-cause dementia in the Framingham Heart Study.
BACKGROUND: Docosahexaenoic acid (DHA) is an abundant fatty acid in the brain. In the diet, DHA is found mostly in fatty fish. The content of DHA has been shown to be decreased in the brain and plasma of patients with dementia. OBJECTIVE: To determine whether plasma phosphatidylcholine (PC) DHA content is associated with the risk of developing dementia. Design, Setting, and PARTICIPANTS: A prospective follow-up study in 899 men and women who were free of dementia at baseline, had a median age of 76.0 years, and were followed up for a mean of 9.1 years for the development of all-cause dementia and Alzheimer disease. MAIN OUTCOME MEASURES: Plasma PC fatty acid levels were measured at baseline. Cox proportional regression analysis was used to assess relative risks of all-cause dementia and Alzheimer disease according to baseline plasma levels. RESULTS: Ninety-nine new cases of dementia (including 71 of Alzheimer disease) occurred during the follow-up. PMID: 17101822 [PubMed - indexed for MEDLINE]